Edges in Network
| Network | GSE16391_egf1520 - GSE16391 - SiGN-BN HC+Bootstrap |
| Network Description | GGI: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial |
| Node | VAV3 |
| Upstream (Parents) |
|---|
| (<<) ACTN1 → VAV3 |
| (<<) ATF2 → VAV3 |
| (<<) ATP2B4 → VAV3 |
| (<<) CHPF → VAV3 |
| (<<) DDX18 → VAV3 |
| (<<) ENO3 → VAV3 |
| (<<) GNG4 → VAV3 |
| (<<) ISLR → VAV3 |
| (<<) PDK1 → VAV3 |
| (<<) PPP3CC → VAV3 |
| (<<) PTMA → VAV3 |
| (<<) RBKS → VAV3 |
| (<<) SMURF1 → VAV3 |
| (<<) STAT2 → VAV3 |
| (<<) STK4 → VAV3 |
| (<<) SYK → VAV3 |
| (<<) TAF1A → VAV3 |
| (<<) TNC → VAV3 |
| Downstream (Children) |
|---|
| VAV3 → HSPA5 (>>) |
| VAV3 → KRT1 (>>) |
| VAV3 → MREG (>>) |
| VAV3 → TMEM175 (>>) |
| VAV3 → UBQLN2 (>>) |
